Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours

By Ellis P.A.   Norman A.   Hill A.   O'Brien M.E.R.   Nicolson M.   Hickish T.   Cunningham D.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1594-1598

Elsevier

Access to resources Recommend Favorite

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein

By Hendrikse N.   Kuipers Folkert   Meijer Coby   Havinga Rick   Bijleveld Charles   Graaf Winette   Vaalburg Willem   Vries Elisabeth  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokineinduced killer cell therapy in hepatobiliary and pancreatic cancer

By              

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 129-133

Science Publishers

Access to resources Recommend Favorite

Biology and Therapy of Hodgkin's Disease

By Wolf J.   Diehl V.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 830-831

Elsevier

Access to resources Recommend Favorite

Rosacea—Yes, It Is a Disease

By  

The Genesis Report - Rx, Vol. 10, Iss. 2, 2001-02 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite